|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 1 (July 1), 1997:
pp. 156-164
Impaired Generation of Bone Marrow B Lymphocytes in Mice Deficient in C/EBP
By
Xueni Chen,
Weimin Liu,
Concetta Ambrosino,
Maria R. Ruocco,
Valeria Poli,
Luigina Romani,
Ileana Quinto,
Susan Barbieri,
Kevin L. Holmes,
Salvatore Venuta, and
Giuseppe Scala
From the Dipartimento di Medicina Sperimentale e Clinica, Università di Reggio Calabria, Catanzaro, Italy; Dipartimento di Biochimica e Biotecnologie Mediche, Università "Federico II," Napoli, Italy; Istituto di Ricerche di Biologia Molecolare P. Angeletti, (IRBM) Pomezia, Roma, Italy; Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, Perugia, Italy; and Laboratory of Molecular Structure and Laboratory of Immunopathology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.
 |
ABSTRACT |
CAAT/enhancer binding proteins (C/EBP) are a family of transcription factors that mediates adipocyte differentiation and the regulation of genes expressed in immune responses and inflammation, such as interleukin-6 (IL-6), IL-8, and granulocyte colony-stimulating factor (G-CSF ). We investigated the role of C/EBP (NF-IL6) in the generation of bone marrow B lymphocytes by taking advantage of C/EBP-/- mice. We found that the expansion of bone marrow (BM) B lymphocytes was impaired in long-term lymphoid cultures from C/EBP-/- mice. Consistent with this finding, the number of BM B cells was decreased in C/EBP-/- mice. Both the levels of IL-7 gene expression and bioactive IL-7 from BM stromal cells were decreased in C/EBP-/- mice. Furthermore, the proliferative responsiveness of BM B-cell precursors to IL-7 was also reduced as compared to wild-type mice, indicating that C/EBP is required for the generation of BM B cells induced by IL-7. Accordingly, IL-7 stimulates the C/EBP DNA-binding activity of normal BM pre-B lymphocytes as well as of 70Z/3 pre-B cells. These results point to C/EBP as a critical signaling molecule in BM B lymphopoiesis.
| |
INTRODUCTION |
MEMBERS OF THE C/EBP1 family of transcription factors play important roles as regulators of cell proliferation and differentiation in response to extracellular stimuli.1-3 The best-characterized C/EBP protein is C/EBP (NF-IL6, IL-6DBP, CAP). C/EBP was first isolated and cloned as a transcription factor required for the induction of the IL-6 gene expression by interleukin-1 (IL-1).1 C/EBP can bind to the regulatory regions of various acute-phase protein genes and several cytokine genes, and transactivates the promoters of these genes.4-7 In normal tissues, C/EBP is expressed at undetectable or very low levels, but is rapidly induced by lipopolysaccharide (LPS) or by cytokines such as tumor necrosis factor- (TNF-) and IL-6.8 In addition, C/EBP expression increases during differentiation of myeloid and plasma cells,9-11 suggesting that C/EBP may also be involved in the differentiation of myeloid and lymphoid cell lineages. Other members of C/EBP family include C/EBP, C/EBP , C/EBP , CHOP, and CRPI.12,13 Among them, C/EBP and C/EBP exhibit an expression pattern similar to that of C/EBP and has been shown to be involved in the regulation of several genes during inflammation and cell differentiation.7,14,15 To investigate specific immunoregulatory functions of C/EBP, we used C/EBP-/- mice16 to study the role of C/EBP in B-cell lymphopoiesis.
The development of B lymphocytes depends on ordered availability of cytokines acting on the proliferation and the differentiation of precursor cells.17 This implies that cytokine genes must be expressed upon the activation of specific transcription factors. However, little is known of the role of trans-activating factors in B-cell lymphopoiesis. We established Whitlock-Witte type long-term and short-term B-lymphoid cultures18,19 of C/EBP-/- mice bone marrow (BM) to investigate the role of C/EBP in B-cell lymphopoiesis. Our results showed an impaired generation of BM B lymphocytes in C/EBP-/- mice. We also found that BM stromal cells from C/EBP-/- mice expressed reduced levels of IL-7, and that B cells generated from short- as well as long-term cultures showed a reduced responsiveness to IL-7 in vitro. Accordingly, the DNA-binding activity of C/EBP was enhanced in nuclear extracts of both BM pre-B lymphocytes and 70Z/3 pre-B cells stimulated with IL-7, indicating that C/EBP plays a critical role in proper B-cell development.
| |
MATERIALS AND METHODS |
Reagents and animals.
Purified recombinant mouse IL-7 was purchased from Pepro Tech Inc (Rocky Hill, NJ). Antimouse IL-7 monoclonal antibody (MoAb) was purchased from R&D systems Europe Ltd (Abingdon, UK). Polyclonal anti-C/EBP Ab was obtained from T. Kishimoto (Department of Medicine III, Osaka University, Osaka, Japan), anti-C/EBP(C-22) Ab was purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA), while a rabbit antiserum to C/EBP was provided by K. Calame (Department of Microbiology, Columbia University, New York, NY). Fluorescein isothiocyanate (FITC)-labeled antimouse IgM and PE antimouse CD45R/B220 were obtained from Pharmingen (San Diego, CA). Cell sorting experiments were performed as previously described20 by using the following reagents: CD45R/B220 (clone RA3-6B2) FITC-labeled,20 antimouse IgM clone LOmm-9 (Zymed, San Francisco, CA), PE-streptavidin (Molecular Probes, Eugene, OR). C/EBP-/- mice were generated as previously described.16 Procedures involving animals and their care were conducted in conformity with national and international laws and policies (EEC Council Directive 86/609, OJ L 358, December 12, 1987; Italian Legislative Decree 116/92, Gazzetta Ufficiale della Repubblica Italiana No. 40, February 18, 1992; NIH Guide for Care and Use of Laboratory Animals, NIH Publication 85-23, 1985).
Cell lines and lymphoid cell cultures.
The CT6 cell line (a kind gift of Dr Brian M.J. Foxwell, The Kennedy Institute of Rheumatology, London, UK) was maintained in complete medium as described.21 The pre-B cell line 70Z/3 (a kind gift of N. Rice, Basic Research Program, NCI, FCRF, Frederick, MD) was maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS) and 50 µmol/L 2-mercaptoethanol (2-ME). Long-term lymphoid cultures were performed as described18 with minor modifications. BM plugs from both 16- to 20-week-old C/EBP-/- and wild-type mice were suspended at 1 × 106/mL in tissue culture medium (RPMI 1640 medium/5% FCS /50 µmol/L 2-ME containing penicillin and streptomycin). Cells were cultured on 10-cm culture dishes and fed with fresh culture medium twice weekly. Nonadherent cells from cultures were examined weekly for B220-bearing cells by flow cytometry. For short-term cultures, CD45/B220+/IgM- or CD45/B220+/IgM- cells were isolated from BMs of C/EBP null or C/EBP wild-type mice by FACS sorting, and cultured in 96-well flat-bottom plates at 2 × 104/0.1 mL culture medium containing RPMI 1640 medium, 15% FCS, 50 µmol/L 2-ME, minimum essential medium (MEM), vitamin, and different concentrations of recombinant murine IL-7 (0.01 to 100 ng/mL), as previously reported.19 The cultures were fed at day 4 with equal volume of fresh medium containing IL-7. On day 7, the cultures were pulsed with 1 µCi/well of [3H]-thymidine (Amersham, Milan, Italy) for 6 hours and harvested. The incorporated radioactivity were determined in a liquid scintillation counter. Isolation of BM adherent cells was obtained as described.22 Briefly, after 2 weeks of culture of BM cells (1 × 107/dish) a confluent adherent layer of cells was established. All culture medium was removed from the cultures and replaced with fresh medium containing 5 µg/mL of mycophenolic acid (MPA) (Sigma Chemicals, St Louis, MO). Three days later, all the MPA-containing medium was replaced with fresh medium. After an additional 3-day incubation, the cycle was repeated. Cultures were maintained for at least 1 week following the last MAP treatment before use. Cell-surface analysis of IL-7 receptors was performed by using a biotinylated IL-7 following streptavidin-PE (R & D Systems Europe Ltd), according to the manufacturer's specifications. At different culture times, nonadherent cells were collected from long-term cultures of BM, washed twice with RDF1 buffer, and resuspended at a final concentration of 4 × 106 cells/mL. Ten microliters of biotinylated IL-7 (10 µg/mL) was added to 25 µL of cell suspensions. Cells were incubated for 1 hour at 4°C, washed, incubated with streptavidin-PE together with FITC-CD45/B220 MoAb, and analyzed by flow cytometry. The isolation of highly purified B220+/IgM- or B220+/IgM+ BM cells was achieved by a Becton Dickinson FACStar Plus (Milan, Italy) equipped with argon and argon-dye lasers as described.20
IL-7 bioassay.
IL-7 bioactivity in culture supernatant from MPA-treated BM adherent cells was determined by adding serial twofold dilutions of the test supernatants or of an IL-7 standard preparation to 5 × 104 CT6 cells in 100 µL/well in triplicate cultures. After 18 hours of incubation at 37°C, cells were pulsed with 1 µCi [3H]-thymidine for the final 6 hours before harvesting. In neutralizing assays, cell culture supernatants or a standard preparation of IL-7 was preincubated with anti-IL-7 antibody or with an isotype-matched mouse IgG (Sigma Chemicals) for 30 minutes at 37°C as reported.19
RNA extraction and IL-7 reverse transcriptase-polymerase chain reaction (RT-PCR).
Total RNA was prepared from MPA-treated adherent cells by cell lysis in guanidine-thiocyanate buffer and acid phenol/chloroform extraction, followed by ethanol precipitation.23 Reverse transcription of mRNA and PCR amplification of cDNA were performed as previously described.24 Briefly, RNA was incubated with buffer, dNTP, random hexamers, RNAse inhibitor, and MuLV-reverse transcriptase at 42°C for 30 minutes. PCR amplification of cDNAs were performed using the following condition: 94°C for 1 minute, 57°C for 1 minute, and 72°C for 2 minutes for 20 cycles. The cycle number was chosen to generate a linear dose-response curve and the amounts of cDNA to be amplified was normalized using the relative expression level of GAPDH. Murine (m) IL-7 and hGAPDH primers were synthesized based on the published cDNA sequence25,26: IL-7 (sense): 5'-ACATCATCTGAGTGCCACA-3'; IL-7 (antisense): 5'-CTCTCAGTAGTCTCTTTAG-3'; GAPDH (sense) 5'-CCATGGAGAAGGCTGGGG-3'; GAPDH (antisense) 5'-CAAAGTTGTCATGGATGACC-3'. The expected amplified PCR products are 355 bp and 194 bp in the case of mIL-7 and mGAPDH, respectively. After amplification, the PCR products were analyzed by agarose gel electrophoresis and Southern blot hybridization with [32P]-radiolabeled mIL-7 cDNA and human GAPDH cDNA probes. Densitometric analysis of IL-7 and GAPDH expression was performed by using an LKB 2202 Ultrascan Laser densitometer (Farmacia, Milan, Italy) assisted by a Hewlett-Packard 3390A integrator (Milan, Italy).
Electrophoretic mobility shift assay.
BM pre-B lymphocytes and 70Z/3 pre-B cells were isolated and cultured as described above. BM pre-B lymphocytes were cultured for 16 hours without IL-7 and stimulated with 10 ng of IL-7 for 2 hours in parallel with 70Z/3 pre-B cells. Nuclear extracts and gel-shift assays were performed as described elsewhere.27,28 After incubation, cells were obtained, washed once in cold phosphate-buffered saline (PBS), and transferred to 1.7-mL microfuge tubes for a second wash in cold PBS. The supernatant was removed and the cell pellet was resuspended in lysing buffer (10 mmol/L HEPES pH 7.9, 1 mmol/L EDTA, 60 mmol/L KCl, 1 mmol/L dithiothreitol [DTT], 1 mmol/L phenylmethylsulfonyl fluoride [PMSF], 0.2% V/V Nonidet P-40 [Sigma Chemicals, Milan, Italy]) for 5 minutes. Nuclei were collected by centrifugation (500g, 5 minutes), rinsed with NP-40-free lysing buffer, and resuspended in 150 µL of buffer containing 250 mmol/L Tris HCl pH 7.8, 20% glycerol, 0.42 mol/L NaCl, 60 mmol/L KCl, 1 mmol/L DTT, and 1 mmol/L PMSF. Nuclei were then subjected to three cycles of freezing and thawing. The suspension was cleared by centrifugation (7,000g, 15 minutes), and aliquots were immediately tested in gel retardation assay or stored in liquid phase N2 until use. Double-stranded oligonucleotides spanning the C/EBP site of the IL6 gene (5'-GATCGGACGGTCACATTGCACAATCTTAATTAAT-3') were synthesized, purified, annealed, and end-labeled with [-32]-ATP (Amersham Corp, Arlington Heights, IL) using polynucleotide kinase (New England Biolabs, Beverly, MA). Equal amounts of cell extracts (5 µg) were incubated in a reaction mixture consisting of 20 µL buffer containing 20 mmol/L HEPES, pH 7.9, 20% glycerol, 100 mmol/L KCl, 0.2 mmol/L EDTA, 0.5 mmol/L DTT, 0.5 mmol/L PMSF, 2 µg poly [d(I-C)] (Boehringer Mannheim, Milan, Italy), for 5 minutes on ice. One microliter of [-32P]-labeled double-stranded probe (0.2 ng, 4 to 6 × 104 cpm) was then added with or without a 100-fold molar excess of wild-type competitor oligonucleotide. In some samples, 1 µL of polyclonal Ab to C/EBP, C/EBP, or to C/EBP was added to the reaction mixtures. The reactions were incubated at room temperature for 30 minutes and run on a 5% acrylamide/bis-acrylamide (30:1) gel in 22.5 mmol/L Tris-borate, 0.5 mmol/L EDTA. Gels were dried and autoradiographed.
View larger version (14K):
[in this window]
[in a new window]
| Fig 1.
Generation of B lymphocytes in long-term cultures of BMs of C/EBP+/+ and C/EBP-/- mice. BM cells of C/EBP+/+ mice and C/EBP-/- mice were cultured at 106/mL in 10-cm tissue-culture dishes as detailed in Materials and Methods. At the indicated times, cultures were examined by flow cytometry for the number of B220+ cells. The data are expressed as the mean ± the standard deviations of five independent experiments.
|
|
| |
RESULTS AND DISCUSSION |
The generation of B lymphocytes is impaired in long-term cultures from BM of C/EBP-/- mice.
We examined the effects of the C/EBP null mutation on long-term B-lymphoid proliferation using CD45/B220 as a general marker of B cells, and the presence of surface IgM as indicative of mature B cells.29,30 In the early phase of the BM culture (up to 4 weeks), B220-bearing cells from C/EBP-/- mice did not show any significant difference compared with equivalent cells from cultures of wild-type mice. Starting at 12 weeks, the generation of B220-bearing cells from C/EBP-/- mice was significantly decreased, leaving few nonadherent cells after 16 weeks (Fig 1). In marked contrast, the number of B220+ cells from wild-type mice increased after 12 weeks of culture to about 1 × 106 per dish at 20 weeks (Fig 1). Although the generation of B lymphocytes in long-term cultures was decreased in C/EBP-/- mice (shown in Fig 2), the distribution of B220+/IgM- (pre-B cells), and B220+/IgM+ (mature B cells) populations among the nonadherent cells did not show any significant difference between C/EBP-/- and wild-type mice. In fact, greater than 90% of cells were B220+ B cells, with 78% carrying the B220+/IgM- phenotype (pre-B cells), and 22% expressing the B220+/IgM+ phenotype (mature B cells) (Fig 3). This indicates that C/EBP deficiency affects selectively the expansion of pre-B lymphocytes from BM precursors, but it does not interfere with B-cell differentiation.
View larger version (43K):
[in this window]
[in a new window]
| Fig 3.
Flow cytometric analysis of nonadherent cells generated in long-term cultures of BM stromal cells. Cells were doubly stained with PE-conjugated antimouse CD45/B220 and with FITC-conjugated antimouse IgM. Greater than 90% of cells are B220+ B cells, with 78% carrying the B220+/IgM- phenotype (pre-B cells), and 22% expressing the B220+/IgM+ phenotype (mature B cells). Solid peaks indicate the staining with isotype-matched MoAb controls. The data are representative of the weekly analysis of BM cultures from 10 individual C/EBP+/+ and C/EBP-/- mice.
|
|
IL-7 gene expression of BM stromal cells is decreased in C/EBP-/- mice.
Generation of precursor B cells in BM depends on stromal cells that act through intracellular contact and via the secretion of growth factors.31 These include IL-7, a cytokine that promotes survival and expansion of early B cells in BM stromal cultures and in vivo.32-34 To determine whether the defective B-lymphoid proliferation in BM of C/EBP-/- mice was related to a decrease in the availability of cytokines involved in B-cell development, we measured IL-7 gene expression from BM stromal cells and the levels of IL-7 in supernatants of long-term cultures of BM stromal cells. Total RNA was prepared from MPA-treated BM adherent cells and the mRNA levels of IL-7 were evaluated by RT-PCR. As shown in Fig 4, IL-7 mRNA expression was about fourfold lower in the C/EBP-/- mice than in the wild-type mice, as seen by densitometric analysis (not shown). The decreased IL-7 mRNA expression was consistent with the lower level of bioactive IL-7 in the culture supernatants of MPA-treated BM adherent cells (Table 1). In these experiments, addition of a neutralizing antibody to IL-7 resulted in about a 75% decrease in the CT-6 proliferative response, suggesting that other factors could participate in the generation of B cells from long-term cultures of BM (Table 1). The levels of other cytokines such as IL-3, IL-4, IL-6, IL-8, IL-10, granulocyte colony-stimulating factor (G-CSF ), and TNF- in culture supernatants of BM adherent cells from C/EBP-/- and wild-type mice were substantially unchanged (data not shown). These results indicate that deletion of C/EBP leads to a selective decrease in IL-7 production from stromal BM cells, and could be partly responsible for the impaired development of B lymphocytes of C/EBP-/- mice.
View larger version (41K):
[in this window]
[in a new window]
| Fig 4.
IL-7 mRNA expression from BM adherent cells of C/EBP+/+ and C/EBP-/- mice. Total RNA was extracted from MPA-treated BM adherent cells of C/EBP+/+ and C/EBP-/- mice. RT-PCR with mouse IL-7-specific primers was performed from the indicated amounts of RNA (0.1 µg, 0.2 µg). IL-7 mRNA expression was visualized by a Southern blot analysis of RT-PCR products in parallel with constitutively expressed GAPDH by using a mouse IL-7 or a human GAPDH cDNA.
|
|
View this table:
[in this window]
[in a new window]
|
Table 1.
Levels of Bioactive IL-7 in Culture Supernatants of BM Adherent Cells From C/EBP(+/+) and C/EBP(-/-) Mice
|
|
IL-7 responsiveness of B-cell precursors from BM of C/EBP-/- mice is impaired.
C/EBP mediates the cell growth and differentiation induced by certain cytokines, including IL-6, IL-8, and G-CSF.1,9,35 To test whether the C/EBP null mutation might result in a decreased responsiveness of C/EBP-/- pre-B cells to IL-7, highly purified B220+/IgM- or B220+/IgM+ B cells were isolated from BMs of C/EBP-/- mice and their wild-type littermates by FACS sorting (Fig 5A). The cells were then analyzed for their ability to proliferate upon IL-7 stimulation. We observed that the proliferative response of BM B-cell precursors from C/EBP-/- mice was dramatically reduced as measured by [3H]-thymidine incorporation and by viable cell counts (Fig 5B). In contrast, no difference was observed in the proliferative response of spleen B lymphocytes to IL-4 in C/EBP-/- and wild-type mice, indicating the absence of an intrinsic proliferative defect in B cells from C/EBP-/- mice (data not shown). The flow cytometric analysis of IL-7 receptors on B220+ B cells either derived from long-term cultures or from short-term cultures of BM showed equivalent levels of IL-7 receptors both in C/EBP-/- and wild-type mice, indicating that the observed lack of IL-7 responsiveness was not caused by decreased levels of IL-7 receptors (Fig 6).
View larger version (25K):
[in this window]
[in a new window]
View larger version (14K):
[in this window]
[in a new window]
| Fig 5.
Proliferative response of BM B-lymphocyte subpopulations of C/EBP+/+ and C/EBP-/- mice to IL-7 stimulation. (A) FACS analysis of sorted B-cell subpopulations. BM cells from C/EBP+/+ and C/EBP-/- mice were stained with CD45/B220-FITC and with antimouse IgM-biotin followed by streptavidin-PE labeling. Cells were sorted in CD45/B220+/IgM- and CD45/B220+/IgM+ cell subsets by FACS sorting, as detailed in Materials and Methods. A purity of greater than 99.5% was consistently achieved. (B) Response of BM B lymphocytes from C/EBP+/+ or C/EBP -/- mice to IL-7 stimulation. CD45/B220+/IgM- and CD45/B220+/IgM+ cell subsets were isolated from BM cells of C/EBP+/+ and C/EBP -/- mice, cultured into 96-well plates at 2 × 104/0.1 mL, and stimulated with the indicated amounts of IL-7. On day 7, cultures were obtained to determine [3H]-thymidine incorporation. The data are expressed as the mean ± the standard deviations of three independent experiments. Similar results were obtained in the case of several independent experiments with B-cell populations obtained from long-term B-cell cultures (not shown).
|
|
View larger version (18K):
[in this window]
[in a new window]
| Fig 6.
Surface expression of IL-7 receptors on B cells from C/EBP+/+ or C/EBP-/- mice. B lymphocytes obtained from long-term cultures of BM stromal cells were stained with B220-FITC MoAb and with IL-7 biotin, followed by incubation with streptavidin-PE. 31.5% and 34.7% of cells expressed IL-7 receptors in the case of C/EBP+/+ or C/EBP-/- mice, respectively. Similar results were obtained in the case of BM B-cell subpopulations (not shown).
|
|
IL-7 can induce C/EBP DNA-binding activity in pre-B cells.
Results shown in Fig 5B suggested that C/EBP transcription factors could mediate the responsiveness of pre-B cells to IL-7. To test whether C/EBP factors were indeed activated in response to IL-7, nuclear extracts were prepared from IL-7-stimulated B220+/IgM- B lymphocytes isolated by fluorescence-activated cell sorting (FACS) sorting from BM cells of C/EBP wild-type mice, as well as 70Z/3 pre-B cells, and tested for binding to a oligonucleotide corresponding to the C/EBP binding site of IL-6 promoter.6 We found that IL-7 stimulation induced a strong increase in C/EBP DNA-binding activity in both BM pre-B cells and in 70Z/3 pre-B cell line (Fig 7). In these experiments addition of antibodies to C/EBP, C/EBP, or to C/EBP resulted in a decrease in DNA-binding, indicating the presence of C/EBP, C/EBP, and C/EBP isoforms in the protein-DNA complexes. In the case of 70Z/3 pre-B cells, no inhibition of C/EBP DNA-binding activity was observed in nuclear extracts tested in the presence of the anti-C/EBP antiserum, indicating that IL-7 does not induce the C/EBP isoform in this cell line (Fig 7). These results identify C/EBP proteins as an intracellular signaling molecule of IL-7.
View larger version (59K):
[in this window]
[in a new window]
| Fig 7.
Induction of C/EBP binding activities by IL-7. BM B220+/IgM- pre-B cells were isolated by FACS sorting as detailed in Materials and Methods. BM pre-B lymphocytes and 70Z/3 pre-B cells were stimulated with IL-7 (10 ng/mL) for 2 hours or left untreated. Nuclear extracts were prepared and incubated with [32P]-labeled C/EBP double-strand oligonucleotide, as described in Materials and Methods. Unlabeled competitor probe was used at 100-fold molar excess. One milliliter of the indicated anti-C/EBP antisera or of preimmune rabbit serum was added to the reaction mixtures. The results of a single experiment are shown as a representative of four other independent experiments.
|
|
In this report we focused on the proliferation of B lymphocytes from BM, which is the primary organ for B lymphopoiesis in adult mice. Our results show that C/EBP is required for a proper generation of BM lymphocytes. We found that this deficiency occurred at the pre-B cell stage and was dependent on IL-7, as suggested by the decreased IL-7 production from C/EBP-/- stromal cells and by the low response of BM B-cell precursors derived from C/EBP-/- mice to IL-7. The defective responsiveness of BM pre-B cells to IL-7 is likely to play a major role in the impaired development of B-cell precursors. In fact, no significant improvement was observed when exogenous IL-7 was added in short-term cultures of BM, or when supernatants from BM cultures of wild-type mice were added to BM cultures of C/EBP-/- mice (data not shown). As BM B lymphocytes from C/EBP-/- mice or from their wild-type littermates expressed equivalent levels of IL-7 receptors (Fig 6), the above data indicate that C/EBP plays a major role in the generation of BM pre-B cells in response to IL-7.
After 25 to 30 weeks of age, the C/EBP-/- mice showed enhanced lymphoid proliferation in vivo, such as splenomegaly.16 In that early study, the BM compartments of C/EBP-/- mice were not examined.16 This prompted us to determine the levels of B220+/IgM- or B220+/IgM+ B cells in BMs of C/EBP-/- or wild-type mice. As shown in Table 2, both the percentages and the absolute numbers of mature B cells as well as B220+/IgM- precursor B cells were reduced in C/EBP-/- BMs. This apparent discrepancy may be explained by the fact that different phases of B-cell development take place in specific lymphoid organs. B-lymphocyte differentiation can be distinguished into two phases: an antigen-independent step which occurs in the BM (the primary lymphoid organ) and the antigen-dependent phase which takes place in the secondary lymphoid organ (eg, spleen lymph nodes, tonsils).36 In the BM, the antigen-independent phase of B-cell differentiation is heavily dependent on cytokines derived from stromal cells, such as IL-7. Differently, the antigen-dependent phase of B-cell differentiation in the secondary organs is mostly dependent on cytokines derived from T lymphocytes such as IL-2, IL-4, IL-6, and interferon-.7,37-39 Moreover, B-cell responses likely result from the combined effects of several cytokines.40-42 Indeed, the peripheral lymphoproliferation observed in the C/EBP-/- mice was age-dependent, and is likely to be of reactive origin due to a disregulation of the T-helper-dependent antibody response.16 In addition, a compensatory mechanism occurring in vivo may be in part responsible for the expansion of the peripheral B-cell compartment in C/EBP-/- mice. It is noteworthy that myelofibrosis syndromes are associated with splenomegaly and extramedullary hemopoiesis.43
C/EBP binding motifs have been identified in the functional regulatory regions of several genes such as G-CSF, TNF-, IL-1, IL-6, and IL-8.2,6,9,35,44 We show here that both the IL-7 production from stromal cells and the proliferative response of pre-B lymphocytes to IL-7 are impaired in C/EBP-/- mice. This suggests that C/EBP is involved both in the regulation of the IL-7 gene expression, and in mediating the IL-7 effects on B cells, particularly those related to the proliferative response of B-cell precursors to IL-7. In this regard, C/EBP could cooperate with other proteins, such as STAT1, STAT3, and STAT5, which function as tyrosine phosphorylated transcription factors in mediating the IL-7 signal transduction.45,46 The molecular basis of the role of C/EBP in B-lymphoid proliferation is not clear. The proliferation of IL-7-dependent B-cell precursors from BM also requires cell contacts involving CD44 and Hyaluronate, interaction of c-kit with stem cell factor (SCF ) and IL-7 receptors.47,48 Moreover, other factors such as insulin-like growth factor 1 (IGF-1), pre-B-cell growth stimulatory factor (pBSF ), pre-B-cell costimulatory factor (BST-1), and Pim-1 gene product were reported to potentiate the B-cell proliferative response.49-52 This suggests that C/EBP deficiency may lead to an impaired generation of B-cell precursors by acting at multiple pathways of B-cell stimulation.
As shown in Fig 7, we observed that IL-7 is a strong inducer of the DNA-binding activity of C/EBP. Despite the similarity in the pattern of expression between C/EBP and C/EBP in normal tissues, the activities of C/EBP and C/EBP are induced by different mechanisms: posttranslational for C/EBP and transcriptional for C/EBP.3 In fact, activation of C/EBP requires threonine phosphorylation induced through the ras-raf-MAP kinases.53 This implies the possibility that IL-7 could activate the ras pathway of signal transduction, in addition to the documented activation of STAT proteins through the -chain of the IL-7 receptor.54 An impaired B-lymphoid development was observed in IL-7-/- and IL-7R-/- mice.55,56 The former showed the BM B lymphopoieis blocked at the transition from pro-B to pre-B cells,55 and the latter displayed a reduction in IL-7 responsiveness of early/late pro-B from BM.56 Our results extend these findings by showing that deletion of the CEBP gene leads to a decrease in both IL-7 production and IL-7 responsiveness. These findings indicate that a defect in B-lymphocyte development can result from a functional deletion of a cytokine or of its receptor, as well as of a gene whose product acts downstream of the signal transduction pathway. A similar feature has been reported in the case of severe immunodeficiency resulting from inactivation of either the common -chain of IL-2, IL-4, and IL-7, or of Jak3 kinase.57-60
Although C/EBP-deficient mice present a lymphoid proliferation in spleen and lymph node, humoral and cellular immunity are profoundly distorted as shown by the increased susceptibility to Candida albicans infection and the altered T-helper function.16 Recently it has been reported that C/EBP-deficient mice were highly susceptible to infection by Listeria monocytogenes and that the tumor cytotoxicity of macrophages was severely impaired in C/EBP-deficient mice.61 These findings, together with the data shown in this study, point to a central role of C/EBP in the functional regulation of lymphoid compartments and in macrophage activation, and indicate C/EBP -/- mice as a suitable model in immunity and inflammation.
| |
FOOTNOTES |
Submitted July 10, 1996;
accepted February 21, 1997.
Supported by grants from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.), from the Consiglio Nazionale delle Ricerche (C.N.R), from A.I.D.S. project of the Istituto Superiore di Sanità, and from Telethon. X.C. was supported by a fellowship from Telethon.
Address reprint requests to Giuseppe Scala, MD, Dipartimento di Biochimica e Biotecnologie Mediche, Via S. Pansini 5, 80131, Napoli, Italy.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
We thank M. Brian and J. Foxwell for providing the CT6 cell line and N. Rice for the gift of 70Z/3 cells. We are grateful to R. Taub and L. Greenbaum for the generous gift of C/EBP-/- and wild-type mice, and K. Calame for providing the anti C/EBP antiserum. We also thank G. Ciliberto for critical reading of the manuscript.
| |
REFERENCES |
1.
Isshik H,
Akira S,
Tanabe O,
Nakajima T,
Shimamoto T,
Hirano T,
Kishimoto T:
Constitutive and IL-1 inducible factors interact with the IL-1 responsive element in the IL-6 gene.
Mol Cell Biol
10:2757,
1990[Abstract/Free Full Text]
2.
Zhang Y,
Ron WN:
Regulation of the interleukin-1 (IL-1) gene by mycobacterial components and lipopolysaccharide mediated by two nuclear factor-IL-6 motifs.
Mol Cell Biol
13:3831,
1993[Abstract/Free Full Text]
3.
Ramji DP,
Vitelli A,
Tronche F,
Cortese R,
Ciliberto G:
The two C/EBP isoforms, IL-6 DBP/NF-IL6 and C/EBP/NF-IL6, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.
Nucleic Acids Res
21:289,
1993[Abstract/Free Full Text]
4.
Chang C,
Chen T,
Lei H,
Chen D,
Lee S:
Molecular cloning of a transcription factor, AGP/EBP that belong to members of the C/EBP family.
Mol Cell Biol
10:6642,
1990[Abstract/Free Full Text]
5.
Descombes P,
Chojkier M,
Lichtsteiner S,
Falvey E,
Schibler U:
LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.
Genes Dev
4:1541,
1990[Abstract/Free Full Text]
6.
Poli V,
Mancini FP,
Cortese R:
IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.
Cell
63:643,
1990[Medline]
[Order article via Infotrieve]
7.
Akira S,
Kishimoto T:
IL-6 and NF-IL6 in acute-phase response and viral infection.
Immunol Rev
127:25,
1992[Medline]
[Order article via Infotrieve]
8.
Akira S,
Isshiki H,
Sugita T,
Tanabe O,
Kinoshita S,
Nishio Y,
Nakajima T,
Hirano T,
Kishimoto T:
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
EMBO J
9:1897,
1990[Medline]
[Order article via Infotrieve]
9.
Natsuka S,
Akira S,
Nishio Y,
Hashimoto S,
Sugita T,
Isshiki H,
Kishimoto T:
Macrophage differentiation specific expression of NF-IL6, a transcription factor for IL-6.
Blood
79:460,
1992[Abstract/Free Full Text]
10.
Scott LM,
Civin CI,
Rorth P,
Friedman AD:
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells.
Blood
80:1725,
1992[Abstract/Free Full Text]
11.
Cooper C,
Johnson D,
Roman C,
Avitahl N,
Tucker P,
Calame K:
The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
J Immunol
149:3225,
1992[Abstract]
12.
Ron D,
Habener JF:
CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.
Genes Dev
6:439,
1992[Abstract/Free Full Text]
13.
Williams SC,
Cantwell CA,
Johnson PF:
A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.
Genes Dev
5:1553,
1991[Abstract/Free Full Text]
14.
Kinoshita S,
Akira S,
Kishimoto T:
A member of the C/EBP family, NF-IL6, forms a heterodimer and transcriptionally synergizes with NF-IL6.
Proc Natl Acad Sci USA
89:1473,
1992[Abstract/Free Full Text]
15.
Cooper C,
Johnson D,
Roman C,
Avithal N,
Ticker P,
Calame K:
The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
J Immunol
149:3225,
1992
16.
Screpanti I,
Romani L,
Musiani P,
Modesti A,
Fattori E,
Lazzaro D,
Sellitto C,
Scarpa S,
Bellavia D,
Lattanzio G,
Bistoni F,
Frati L,
Cortese R,
Gulino A,
Ciliberto G,
Coslantini F,
Poli V:
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP-deficient mice.
EMBO J
14:1932,
1995[Medline]
[Order article via Infotrieve]
17.
Ryan DH,
Nuccie BL,
Ritterman I,
Liesveld JL,
Abboud CN:
Cytokine regulation of early human lymphopoiesis.
J Immunol
152:5250,
1994[Abstract]
18.
Whitlock CA,
Witte ON:
Long-term culture of B lymphocytes and their precursors from murine bone marrow.
Proc Natl Acad Sci USA
79:3608,
1982[Abstract/Free Full Text]
19.
Griffiths SD,
Goodhead DT,
Marsden SJ,
Wright EG,
Krajewski S,
Reed JC,
Korsmeyer SJ,
Greaves M:
Interleukin-7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis.
J Exp Med
179:1789,
1994[Abstract/Free Full Text]
20.
Holmes KL,
Lantz LM,
Lee JS,
Bedigia HG,
Taubenberger JK:
Characterization of a new antigen expressed by B and myeloid lineage cells identified by the monoclonal antibody LIP-6.
Cell Immunol
166:131,
1995[Medline]
[Order article via Infotrieve]
21.
Willcocks J. L,
Hales A,
Page TH,
Foxwell BMJ:
The murine T cell line CT6 provides a novel bioassay for interleukin-7.
Eur J Immunol
23:716,
1993[Medline]
[Order article via Infotrieve]
22.
Dorshkind K,
Johnson A,
Collins L,
Keller GM,
Phillips RA:
Generation of purified stromal cell culture that supports lymphoid and myeloid precursors.
J Immunol Methods
89:37,
1986[Medline]
[Order article via Infotrieve]
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biochemistry 162:156, 1987
24.
Scala G,
Ruocco MR,
Ambrosino C,
Mallardo M,
Giordano V,
Baldassarre F,
Dragonetti E,
Quinto I,
Venuta S:
The expression of interleukin 6 is induced by the human immunodeficiency virus 1 TAT protein.
J Exp Med
179:961,
1994[Abstract/Free Full Text]
25.
Potocnik A,
Nielsen PJ,
Eichmann K:
In vitro generation of lymphoid precursors from embryonic stem cells.
EMBO J
13:5274,
1994[Medline]
[Order article via Infotrieve]
26.
Christ M,
McCartney-Francis NL,
Kulkarni AB,
Ward JM,
Mizel DE,
Mackall CL,
Gress RE,
Hines KL,
Tian H,
Karlsson S,
Wahl SM:
Immune dysregulation in TGF-1-deficient mice.
J Immunol
153:1936,
1994[Abstract]
27.
Gorman CM,
Moffat LF,
Howard BH:
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol Cell Biol
2:1044,
1982[Abstract/Free Full Text]
28.
Ruocco MR,
Chen X,
Ambrosino C,
Dragonetti E,
Liu W,
Mallardo M,
De Falco G,
Palmieri C,
Franzoso G,
Quinto I,
Venuta S,
Scala G:
Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6 and NF-kB/rel transcription factors.
J Biol Chem
271:22479,
1996[Abstract/Free Full Text]
29.
Park Y,
Osmond DG:
Phenotype and proliferation of early B lymphocyte precursor cells in mouse bone marrow.
J Exp Med
165:444,
1987[Abstract/Free Full Text]
30.
Funk PE,
Varas A,
Witte PL:
Activity of stem cell factor and IL-7 in combination on normal bone marrow B lineage cells.
J Immunol
150:748,
1993[Abstract]
31.
Cushley W,
Harnett MM:
Cellular signalling mechanisms in B lymphocytes.
Biochem J
292:313,
1993
32.
Namen AE,
Lupton S,
Hjerrild K,
Wignall J,
Mochizuki DY,
Schmierer A,
Mosley B,
March CJ,
Urdal D,
Gillis S:
Stimulation of B-cell progenitors by cloned murine interleukin-7.
Nature
333:571,
1988[Medline]
[Order article via Infotrieve]
33.
Sudo T,
Ito M,
Ogawa Y,
Iizuka M,
Kodama H,
Kunisada T,
Hayashi S,
Ogawa M,
Sakai K,
Nishikawa S:
Interleukin 7 production and function in stromal cell-dependent B cell development.
J Exp Med
170:333,
1989[Abstract/Free Full Text]
34.
Grabstein HH,
Waldschmidt TJ,
Finkelman FD,
Hess BW,
Alpert AR,
Boiani NE,
Namen AE,
Morrissey PJ:
Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody.
J Exp Med
178:257,
1993[Abstract/Free Full Text]
35.
Mukaida N,
Mahe Y,
Matsushima K:
Cooperative interaction of NF- B-and C/EBP-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines.
J Biol Chem
265:21128,
1990[Abstract/Free Full Text]
36.
Rolink A,
Melchers F:
Molecular and cellular origin of lymphocyte diversity.
Cell
66:1081,
1991[Medline]
[Order article via Infotrieve]
37.
Jelinek DF,
Splawski JB,
Lipsky PE:
The roles of interleukin 2 and interferon- in human B cell activation, growth and differentiation.
Eur J Immunol
16:925,
1986[Medline]
[Order article via Infotrieve]
38.
Lutzker S,
Rothman P,
Pollock R,
Coffman R,
Alt FW:
Mitogen-and IL-4-regulated expression of germ line IgG 2b transcripts: Evidence for directed heavy chain class switching.
Cell
53:177,
1988[Medline]
[Order article via Infotrieve]
39.
Stavnezer J,
Radcliffe G,
Lin Y,
Nietupski J,
Berggren L,
Sitia R,
Severinson E:
Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant-region genes.
Proc Natl Acad Sci USA
85:7704,
1988[Abstract/Free Full Text]
40.
Robb RJ,
Rusk CM,
Yodoi J,
Greene WC:
Interleukin 2 binding molecule distinct from the Tac protein: Analysis of its role in formation of high-affinity receptors.
Proc Natl Acad Sci USA
84:2002,
1987[Abstract/Free Full Text]
41.
Jelinek DF,
Lipsky PE:
Inhibitory influence of IL-4 on human B cell responsiveness.
J Immunol
141:164,
1988[Abstract]
42.
Lorente LL,
Mitjavila F,
Crevon M,
Galanaud P:
Dual effects of interleukin 4 on antigen-activated human B cells: Induction of proliferation and inhibition of interleukin 2-dependent differentiation.
Eur J Immunol
20:1887,
1990[Medline]
[Order article via Infotrieve]
43. Susan, BS: 1995. Disorders of the spleen, in Handin RB, Samuel EL, Stossel TT (eds): Blood: Principles and Practice. Philadelphia, PA, Lippincott, 1995, p 1359
44.
Lowenstein CJ,
Alley EW,
Raval P,
Snowman AM,
Snyder SH,
Russell SW,
Murphy WJ:
Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon and lipopolysaccharide.
Proc Natl Acad Sci USA
90:9730,
1993[Abstract/Free Full Text]
45.
Johnston JA,
Bacon CM,
Riedy MC,
O'Shea JJ:
Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.
J Leukoc Biol
60:441,
1996[Abstract]
46.
Kishimoto T,
Taga T,
Akira S:
Cytokine signal transduction.
Cell
76:253,
1994[Medline]
[Order article via Infotrieve]
47.
Miyake K,
Underhill CB,
Lesley J,
Kincade PW:
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
J Exp Med
172:69,
1990[Abstract/Free Full Text]
48.
Rolink A,
Streb M,
Nishikawa SI,
Melchers F:
The C-kit encoded tyrosine kinase regulates the proliferation of early pre-B cell.
Eur J Immunol
21:2609,
1991[Medline]
[Order article via Infotrieve]
49.
Landreth KS,
Narayanan R,
Dorshkind K:
Insulin-like growth factor (IGF-1) regulates pro-B cell differentiation.
Blood
80:1207,
1992[Abstract/Free Full Text]
50.
Nagasawa T,
Kikutani H,
Kishimoto T:
Molecular cloning and structure of a pre-B-cell growth stimulating factor.
Proc Natl Acad Sci USA
91:2305,
1995[Abstract/Free Full Text]
51.
Wakatsuki Y,
Neurath MF,
Max EE,
Strober W:
The B cell-specific transcription factor BSAP regulates B cell proliferation.
J Exp Med
179:1099,
1994[Abstract/Free Full Text]
52.
Domen J,
Lugt NMT,
Acton D,
Laird PW,
Linders K,
Berns A:
Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.
J Exp Med
178:1665,
1993[Abstract/Free Full Text]
53.
Nakajima T,
Kinoshita S,
Sasagawa T,
Sasaki K,
Naruto M,
Kishimoto T,
Akira S:
Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.
Proc Natl Acad Sci USA
90:2207,
1993[Abstract/Free Full Text]
54.
Lin J,
Migone T,
Tsang M,
Friedmann M,
Weatherbee JA,
Zhou L,
Yamauchi A,
Bloom ET,
Mietz J,
John S,
Leonard WJ:
The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15.
Immunity
2:331,
1995[Medline]
[Order article via Infotrieve]
55.
Freeden-Jeffry UV,
Vieira P,
Lucian LA,
McNeil T,
Burdach SG,
Murray R:
Lymphopenia in interleukin(IL)-7 gene-deleted mice identifies IL-7 as a non redundant cytokine.
J Exp Med
181:1519,
1995[Abstract/Free Full Text]
56. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955, 1994
57.
Di Santo JP,
Muller W,
Guy-Grand D,
Fischer A,
Rajewsky K:
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor chain.
Proc Natl Acad Sci USA
92:377,
1995[Abstract/Free Full Text]
58.
Thomis DC,
Gurniak CB,
Tivol E,
Sharpe AH,
Berg LJ:
Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3.
Science
270:794,
1995[Abstract/Free Full Text]
59.
Russell SM,
Tayebi N,
Nakajima H,
Riedy MC,
Roberts JL,
Aman MJ,
Migone TS,
Noguchi M,
Markert ML,
Buckeley RH,
O'Shea JJ,
Leonard JW:
Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development.
Science
270:797,
1995[Abstract/Free Full Text]
60.
Nosaka T,
van Deursen JMA,
Tripp RA,
Thierfelder WE,
Witthuhn BA,
McMicckle AP,
Doherty PC,
Grosveld GC,
Ihle JN:
Defective lymphoid development in mice lacking Jak3.
Science
270:800,
1995[Abstract/Free Full Text]
61.
Tanaka T,
Akira S,
Yoshid K,
Umemoto M,
Yoneda Y,
Shirafuji N,
Fujiwara H,
Suematsu S,
Yoshida N,
Kishimoto T:
Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages.
Cell
80:353,
1995[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. W. Cochrane, Y. Zhao, R. S. Welner, and X.-H. Sun
Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions
Blood,
January 29, 2009;
113(5):
1016 - 1026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li, P. Gade, S. C. Nallar, A. Raha, S. K. Roy, S. Karra, J. K. Reddy, S. P. Reddy, and D. V. Kalvakolanu
The Med1 Subunit of Transcriptional Mediator Plays a Central Role in Regulating CCAAT/Enhancer-binding Protein-{beta}-driven Transcription in Response to Interferon-{gamma}
J. Biol. Chem.,
May 9, 2008;
283(19):
13077 - 13086.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Akagi, T. Saitoh, J. O'Kelly, S. Akira, A. F. Gombart, and H. P. Koeffler
Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP{beta}-deficient hematopoietic cells
Blood,
March 15, 2008;
111(6):
2999 - 3004.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Boggs and D. Reisman
C/EBPbeta Participates in Regulating Transcription of the p53 Gene in Response to Mitogen Stimulation
J. Biol. Chem.,
March 16, 2007;
282(11):
7982 - 7990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Quintanilla-Martinez, S. Pittaluga, C. Miething, M. Klier, M. Rudelius, T. Davies-Hill, N. Anastasov, A. Martinez, A. Vivero, J. Duyster, et al.
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma
Blood,
September 15, 2006;
108(6):
2029 - 2036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Guerzoni, M. Bardini, S. A. Mariani, G. Ferrari-Amorotti, P. Neviani, M. L. Panno, Y. Zhang, R. Martinez, D. Perrotti, and B. Calabretta
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
Blood,
May 15, 2006;
107(10):
4080 - 4089.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Roy, J. D. Shuman, L. C. Platanias, P. S. Shapiro, S. P. M. Reddy, P. F. Johnson, and D. V. Kalvakolanu
A Role for Mixed Lineage Kinases in Regulating Transcription Factor CCAAT/Enhancer-binding Protein-{beta}-dependent Gene Expression in Response to Interferon-{gamma}
J. Biol. Chem.,
July 1, 2005;
280(26):
24462 - 24471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Meng, A. Raha, S. Roy, J. Hu, and D. V. Kalvakolanu
IFN-{gamma}-Stimulated Transcriptional Activation by IFN-{gamma}-Activated Transcriptional Element-Binding Factor 1 Occurs via an Inducible Interaction with CAAAT/Enhancer-Binding Protein-{beta}
J. Immunol.,
May 15, 2005;
174(10):
6203 - 6211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Piwien-Pilipuk, O. MacDougald, and J. Schwartz
Dual Regulation of Phosphorylation and Dephosphorylation of C/EBPbeta Modulate Its Transcriptional Activation and DNA Binding in Response to Growth Hormone
J. Biol. Chem.,
November 8, 2002;
277(46):
44557 - 44565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Welm, N. A. Timchenko, Y. Ono, H. Sorimachi, H. S. Radomska, D. G. Tenen, J. Lekstrom-Himes, and G. J. Darlington
C/EBPalpha Is Required for Proteolytic Cleavage of Cyclin A by Calpain 3 in Myeloid Precursor Cells
J. Biol. Chem.,
September 6, 2002;
277(37):
33848 - 33856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Roy, J. Hu, Q. Meng, Y. Xia, P. S. Shapiro, S. P. M. Reddy, L. C. Platanias, D. J. Lindner, P. F. Johnson, C. Pritchard, et al.
MEKK1 plays a critical role in activating the transcription factor C/EBP-beta -dependent gene expression in response to IFN-gamma
PNAS,
June 11, 2002;
99(12):
7945 - 7950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Zhang, E. Nelson, H. S. Radomska, J. Iwasaki-Arai, K. Akashi, A. D. Friedman, and D. G. Tenen
Induction of granulocytic differentiation by 2 pathways
Blood,
May 29, 2002;
99(12):
4406 - 4412.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. C. Jones, M.-L. Lin, S.-S. Chen, U. Krug, W.-K. Hofmann, S. Lee, Y.-H. Lee, and H. P. Koeffler
Expression of C/EBPbeta from the C/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo
Blood,
March 15, 2002;
99(6):
2032 - 2036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Okada, T. Yoshida, Z. Hong, G. Ishii, M. Hatano, M. Kuro-o, Y. Nabeshima, Y.-i. Nabeshima, and T. Tokuhisa
Impairment of B lymphopoiesis in precocious aging (klotho) mice
Int. Immunol.,
June 1, 2000;
12(6):
861 - 871.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Roy, S. J. Wachira, X. Weihua, J. Hu, and D. V. Kalvakolanu
CCAAT/Enhancer-binding Protein-beta Regulates Interferon-induced Transcription through a Novel Element
J. Biol. Chem.,
April 21, 2000;
275(17):
12626 - 12632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kim, P.-L. Mao, M. Gagliardi, and P.-A. Bedard
C/EBPbeta (NF-M) Is Essential for Activation of the p20K Lipocalin Gene in Growth-Arrested Chicken Embryo Fibroblasts
Mol. Cell. Biol.,
August 1, 1999;
19(8):
5718 - 5731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Boruk, J. G. A. Savory, and R. J. G. Haché
AF-2-Dependent Potentiation of CCAAT Enhancer Binding Protein {beta}-Mediated Transcriptional Activation by Glucocorticoid Receptor
Mol. Endocrinol.,
November 1, 1998;
12(11):
1749 - 1763.
[Abstract]
[Full Text]
|
|
|
|
|
Abstract
Introduction
Abstract
